Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution & Placebo (Nepafenac Vehicle) for the Prevention & Treatment of Ocular Inflammation & Ocular Pain Associated with Cataract Surgery. European Study

Trial Profile

Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution & Placebo (Nepafenac Vehicle) for the Prevention & Treatment of Ocular Inflammation & Ocular Pain Associated with Cataract Surgery. European Study

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Dec 2018

At a glance

  • Drugs Nepafenac (Primary) ; Ketorolac
  • Indications Ocular inflammation; Ocular pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Alcon
  • Most Recent Events

    • 13 Dec 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top